Lingguizhugan oral solution alleviates MASLD by regulating bile acids metabolism and the gut microbiota through activating FXR/TGR5 signaling pathways

• Main Authors: Jiahua Wang (Author), Juan Zang (Author), Yang Yu (Author), Yang Liu (Author), Huimin Cao (Author), Ruibo Guo (Author), Lu Zhang (Author), Mo Liu (Author), Zixu Zhang (Author), Xuetao Li (Author), Liang Kong (Author)
• Format: Book
• Published: Frontiers Media S.A., 2024-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

BackgroundThe preservation of the Lingguizhugan (LGZG) decoction and patient compliance issue often limit the treatment of metabolic dysfunction-associated steatotic liver disease (MASLD). Hence, herein, an LGZG oral solution was developed for alleviating MASLD. Additionally, the potential mechanism...